VV
Vasant Vallabhdas Sangani
About Vasant Vallabhdas Sangani
Data last updated:
Vasant Vallabhdas Sangani is a Director at Vajrachem India Limited (since 2022), Director at Vrinda Chemicals (India) Private Limited (since 2008) and Director at Nuvvagen Bioscience Private Limited (since 2019), and holds 1 more current directorship. The companies operate in Chemicals and Materials, Healthcare and Real Estate and Construction. The 3 current companies with reported revenue have a combined latest revenue of ₹35.77 Cr; the largest is Vajrachem India Limited at ₹23.50 Cr (FY 2024). Earlier, Vasant Vallabhdas Sangani was a Designated Partner at Vamchem Specialities Llp (from 2015).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 24 Mar 2022 | 2022 | ₹23.50 Cr (FY 2024) | Active | |
| Director | 04 Jun 2008 | 2008 | ₹10.92 Cr (FY 2025) | Active | |
| Director | 19 Sep 2019 | 2019 | ₹1.35 Cr (FY 2025) | Active | |
| Designated Partner | 10 Apr 2020 | 2020 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 29 Dec 2015 | 2015 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Vasant Vallabhdas Sangani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dhavall Sangani | 08566890 | Vajrachem India Limited , Nuvvagen Bioscience Private Limited | Director |
| Sonal Vasant Sangani | 09546672 | Vajrachem India Limited | Director |
| Devang Jayantilal Sangani | 02055080 | Vrinda Chemicals (India) Private Limited | Director |
| Kinjan Jayantilal Sangani | 02055122 | Vrinda Chemicals (India) Private Limited | Director |
| Dhirajbhai Dhameliya | 08720958 | Vajra Reaalty Llp | Designated Partner |
| Gaurav Lalitbhai Suvagiya | 08720966 | Vajra Reaalty Llp | Designated Partner |
| Govindbhai Dhamelia | 08720959 | Vajra Reaalty Llp | Designated Partner |
| Jayantilal Vallabhdas Sangani | 08720965 | Vajra Reaalty Llp | Designated Partner |
| Lalitkumar Bhimjibhai Suvagiya | 02633750 | Vajra Reaalty Llp | Designated Partner |
| Muljibhai Dhamelia | 08720941 | Vajra Reaalty Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vasant Vallabhdas Sangani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vasant Vallabhdas Sangani
Vasant Vallabhdas Sangani currently holds 4 directorships: Vajrachem India Limited (Director, since 24 Mar 2022, revenue ₹23.50 Cr (FY 2024)); Vrinda Chemicals (India) Private Limited (Director, since 04 Jun 2008, revenue ₹10.92 Cr (FY 2025)); Nuvvagen Bioscience Private Limited (Director, since 19 Sep 2019, revenue ₹1.35 Cr (FY 2025)); Vajra Reaalty Llp (Designated Partner, since 10 Apr 2020).
Vasant Vallabhdas Sangani was first appointed on 04 Jun 2008 as Director at Vrinda Chemicals (India) Private Limited. The most recent appointment on record is 24 Mar 2022 at Vajrachem India Limited.
The 3 current companies of Vasant Vallabhdas Sangani that report revenue have a combined latest revenue of ₹35.77 Cr: Vajrachem India Limited ₹23.50 Cr (FY 2024); Vrinda Chemicals (India) Private Limited ₹10.92 Cr (FY 2025); Nuvvagen Bioscience Private Limited ₹1.35 Cr (FY 2025).
Vasant Vallabhdas Sangani held 1 earlier board appointment: Vamchem Specialities Llp (Designated Partner, from 29 Dec 2015).
The current boards of Vasant Vallabhdas Sangani's companies include Dhavall Sangani (Vajrachem India Limited), Sonal Vasant Sangani (Vajrachem India Limited), Devang Jayantilal Sangani (Vrinda Chemicals (India) Private Limited), Kinjan Jayantilal Sangani (Vrinda Chemicals (India) Private Limited), Dhirajbhai Dhameliya (Vajra Reaalty Llp), Gaurav Lalitbhai Suvagiya (Vajra Reaalty Llp), among others.